Reducing Rebleeding After Endoscopic Therapy of Dieulafoy Lesions

Use of Doppler probe guidance resulted in less rebleeding compared with visually guided therapy.

Although Dieulafoy lesions (DLs) are an unusual cause of upper gastrointestinal bleeding (UGIB), they are responsible for approximately 10% of severe UGIB cases, in which rebleeding is not uncommon. In the current retrospective study, investigators evaluated the impact of Doppler endoscopic probe (DEP)–guided therapy compared with standard visually guided hemostasis on 30-day DL-related rebleeding.

The study cohort comprised 82 patients with DL-related severe UGIB receiving treatment from a group of experts in endoscopic hemostasis over several decades. Among patients' characteristics, 75% were men, 40% had onset of bleeding during hospitalization for a nonbleeding indication, 44% had cardiovascular disease, 23% had cirrhosis, 16% had end-st…

Reviewing Author

John R. Saltzman, MD

Disclosures

Consultant/Advisory BoardIterative Scopes

Editorial BoardsGastrointestinal Endoscopy; UpToDate

Leadership Positions in Professional SocietiesAmerican College of Gastroenterology (Trustee)

OtherVice President of Medical Affairs, 1Globe Health Institute